Woojung Bio Non-Registered Executive Ham Seok-hee Acquires 5000 Shares in Open Market Purchase, Indicating Insider Confidence and Minimal Dilution Impact

Woojung Bio non-registered executive Ham Seok-hee acquired 5,000 common shares through open market purchases from May 29 to June 4, 2026.
The acquisition prices ranged from 2,485 to 2,795 KRW per share, increasing his total stake to 0.03% of the 16,829,576 outstanding shares.
This is a new report with no capital changes or dilution effects.
The small open market purchase may signal insider confidence but has limited practical impact on the stock price.
[AI Summary]Woojung Bio non-registered executive's small open market purchase indicates insider confidence but the infinitesimal 0.03% stake has negligible price impact. No capital raising or dilution occurs.